NEW YORK, NY / ACCESSWIRE / July 23, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.
Tufin Software Technologies Ltd. (NYSE:TUFN)
Affected investors purchased TUFN securities pursuant and/or traceable to documents issued in connection with the Company's April 2019 initial public offering and/or its December 2019 secondary public offering
A class action has commenced on behalf of certain shareholders in Tufin Software Technologies Ltd. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Tufin's customer relationships and growth metrics were overstated, particularly with respect to North America; (ii) Tufin's business was deteriorating, primarily in North America; (iii) as a result, Tufin's representations regarding its sustainable financial prospects were overly optimistic; and (iv) as a result, the documents issued in connection with the Company's initial public offering were materially false and/or misleading and failed to state information required to be stated therein.
Shareholders may find more information at https://securitiesclasslaw.com/securities/tufin-software-technologies-ltd-loss-submission-form/?id=8148&from=1
Sorrento Therapeutics, Inc. (NASDAQ:SRNE)
Investors Affected: May 15, 2020 - May 22, 2020
A class action has commenced on behalf of certain shareholders in Sorrento Therapeutics, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the Company's initial finding of "100% inhibition" in an in vitro virus infection will not necessarily translate to to success or safety in vivo, or in person; (ii) the Company's finding was not a "cure" for COVID-19; and (ii) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Shareholders may find more information at https://securitiesclasslaw.com/securities/sorrento-therapeutics-inc-loss-submission-form/?id=8148&from=1
Brookdale Senior Living Inc. (NYSE:BKD)
Investors Affected: August 10, 2016 - April 29, 2020
A class action has commenced on behalf of certain shareholders in Brookdale Senior Living Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Brookdale's financial performance was sustained by, among other things, the Company's purposeful understaffing of its senior living communities; (ii) the foregoing conduct subjected Brookdale to an increased risk of litigation and, once revealed, was foreseeably likely to have a material negative impact on the Company's financial results and reputation; (iii) as a result, the Company's financial results were unsustainable; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.
Shareholders may find more information at https://securitiesclasslaw.com/securities/brookdale-senior-living-inc-loss-submission-form/?id=8148&from=1
The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Phone: (212) 537-9430
Fax: (833) 862-7770
SOURCE: The Gross Law Firm
View source version on accesswire.com: